Market Overview:
The global varicose vein treatment market size reached US$ 415.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 579.5 Million by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
Varicose vein treatment comprises self-care measures, compression stockings, and surgeries, such as sclerotherapy, laser treatment, catheter-based radiofrequency, high ligation and vein stripping, and ambulatory phlebectomy. It assists in treating twisted and enlarged veins that are close to the surface of the skin. It also helps reduce ache or heavy feeling in the legs, worsened pain after sitting or standing for a long time, itching around one or more of the veins, changes in skin color around varicose veins, and burning, throbbing, muscle cramping and swelling in the lower legs. As a result, it finds applications in hospitals, clinics, and ambulatory centers worldwide.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Varicose Vein Treatment Market Trends:
Presently, the rising prevalence of varicose vein problems among individuals, along with the growing geriatric population, represents one of the key factors driving the market across the globe. Moreover, there is an increase in the advancement of varicose vein treatment devices. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. In addition, the growing adoption of minimally invasive treatment procedures due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market around the world. Besides this, the rising awareness among individuals about the treatment is offering lucrative growth opportunities to industry investors. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce advanced equipment, such as varithena and VenaSeal closure systems. In line with this, the increasing obesity among individuals due to changing lifestyles and lack of exercise is catalyzing the demand for varicose vein treatment. Other growth-inducing factors are technological advancements, prolonged standing hours at work, and excessive smoking.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global varicose vein treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, procedure and end user.
Breakup by Product:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Ablation Devices
- Radiofrequency Ablation Devices
- Laser Ablation Devices
- Others
- Sclerotherapy Injection
- Others
Breakup by Procedure:
- Injection Sclerotherapy
- Endovenous Ablation
- Surgical Ligation and Stripping
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Centers
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Million |
Segment Coverage |
Product, Procedure, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global varicose vein treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global varicose vein treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the procedure?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global varicose vein treatment market and who are the key players?
- What is the degree of competition in the industry?